Mitigation at che clinical significance of spurious elevations of cardiac troponin I in settings of coronary ischemia using serial testing of multiple cardiac markers

Citation
Sm. Ng et al., Mitigation at che clinical significance of spurious elevations of cardiac troponin I in settings of coronary ischemia using serial testing of multiple cardiac markers, AM J CARD, 87(8), 2001, pp. 994-999
Citations number
26
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
AMERICAN JOURNAL OF CARDIOLOGY
ISSN journal
00029149 → ACNP
Volume
87
Issue
8
Year of publication
2001
Pages
994 - 999
Database
ISI
SICI code
0002-9149(20010415)87:8<994:MACCSO>2.0.ZU;2-V
Abstract
The ability to differentiate between true positives, false positives, and s poradically elevated cardiac troponin levels has grown in importance as car diac troponins assume an increasingly dominant role in the diagnosis of cor onary syndromes. In a population sample of 1,000 patients who presented con secutively to a large urban hospital emergency room, 50 of 112 patients who had elevated troponin levels (>0.6 ng/ml) during evaluation for myocardial injury were subsequently found to have had an isolated, spurious elevation of cardiac troponin, and not a diagnosed myocardial infarction, Logistic r egression analysis shows that by hierarchically analyzing electrocardiograp hic changes with concurrent creating kinase-MB and myoglobin levels at the time of the troponin elevation, one may predict with 91% accuracy whether t he troponin elevation is actually indicative of a myocardial infarction in a patient. Spurious troponin elevations may be a common occurrence, and if not detected, may result in on increased number of falsely diagnosed myocar dial infarctions. (C) 2001 by Excerpta Medica, Inc.